Showing results (91-100 of 378) with videos related to
Sort By:
Pageof 38
Leukemia & Lymphoma|September 1, 1995
VAD-cyclosporine therapy for VAD-resistant multiple myelomaD Weber, M Dimopoulos, F Sinicrope, et al.Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.Blood|March 1, 1989
Plasma cell myeloma--new biological insights and advances in therapyB Barlogie, J Epstein, P Selvanayagam, et al.Blood|September 1, 1983
Prednisone pulse therapy for refractory myelomaR Alexanian, B S Yap, G P BodeyThe International Journal of Biochemistry & Cell Biology|May 14, 2013
Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levelsArshak R Alexanian, Qing-song Liu, Zhiying ZhangBone Marrow Transplantation|June 29, 2000
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agentA Zomas, N Anagnostopoulos, M A DimopoulosLeukemia|July 6, 2007
The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myelomaE Terpos, M-A Dimopoulos, O SezerHematology/Oncology Clinics of North America|January 8, 2000
Waldenström's macroglobulinemiaM A Dimopoulos, E Galani, C MatsoukaArzneimittel-Forschung|December 1, 1996
Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochlorideA R Alexanian, N S Arutyunian, A A GaloyanJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myelomaB Barlogie, W S Velasquez, R Alexanian, et al.Pageof 38